Prenetics Global Ltd (NASDAQ: PRE)

Prenetics Global Ltd is a global consumer health company focused on empowering individuals to take control of their health through innovative science-backed solutions. The company decentralizes and democratizes healthcare by delivering accessible personalized and preventive health products. Its core activities include consumer health brands, consumer genetic testing, and precision oncology diagnostics.

Prenetics generates revenue through the sale of premium health and wellness supplements, sports nutrition distribution, consumer genetic testing kits, and genomic profiling services for cancer patients. The company sells directly to consumers via online platforms and through business-to-business channels with hospitals, physicians, fitness centers, and retail outlets. Revenue is derived from product sales, subscription plans, and service fees for testing and distribution.

The company operates through the following segments: Consumer Health, Prevention, and Diagnostics.

• Consumer Health includes IM8 Health, a premium supplements brand offering scientifically formulated products for longevity performance and overall well-being, and Europa Sports Partners, a leading U. S. distributor of nutritional and sports supplements, beverages, and fitness accessories that also provides wholesale distribution, retail support, private label manufacturing, and e-commerce enablement services.

• Prevention includes CircleDNA, a consumer genetic testing brand utilizing next-generation sequencing technology to deliver comprehensive DNA reports covering health wellness disease risks drug responses and personal traits, complemented by tele-consultations and a mobile application for tracking results and accessing insights.

• Diagnostics includes ACT Genomics, an Asia-based precision oncology company providing FDA-cleared comprehensive genomic profiling tests for solid tumors to enable personalized therapy and support drug discovery, with services distributed through hospital and physician partners in Taiwan, Hong Kong, United Kingdom, Thailand, and other Southeast Asian countries.

Prenetics operates in highly competitive markets across its business units. In consumer health, it competes with established supplement brands such as Nestlé Health Science, Thorne, and Ritual, as well as direct-to-consumer brands like Athletic Greens and Huel. In sports nutrition distribution, it faces competition from GNC, The Vitamin Shoppe, Amazon, and Bodybuilding.com. In consumer genetic testing, it competes with Ancestry, MyHeritage, and Nebula Genomics. In precision oncology, its main competitors are Exact Sciences, Personalis, Foundation Medicine, and Guardant Health. The company differentiates itself through science-backed formulations, clinical validation, proprietary algorithms, next-generation sequencing technology, and strategic partnerships with entities like Mayo Clinic and Tencent.

Prenetics serves a diverse customer base including individual consumers purchasing supplements and genetic tests online, fitness centers and retail outlets purchasing sports nutrition products, and hospitals and oncologists utilizing precision oncology services for cancer patients. Specific customer names are not disclosed in the filing.